Tamsulosin Hydrochloride Capsule
Product Images NDC 82009-025

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 82009-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Tamsulosin (B24163d2 7af8 49c1 A85c 1cd015e29dd0 01)

Chemical structure of Tamsulosin Hydrochloride, showing the molecular arrangement with aromatic rings, functional groups including methoxy, ethoxy, sulfonamide, and hydrochloride components.*

FDA Label Image

Structured Formula For Tamsulosin (B24163d2 7af8 49c1 A85c 1cd015e29dd0 02)

A line graph showing plasma concentration (mg/mL) over time (hours) with two curves representing fasted and fed states. The fasted curve peaks higher and earlier than the fed curve, illustrating differences in drug plasma concentration after dosing under fed versus fasted conditions.*

FDA Label Image

Structured Formula For Tamsulosin (B24163d2 7af8 49c1 A85c 1cd015e29dd0 03)

A line graph depicting the mean change over a 13-week treatment period for Tamsulosin Hydrochloride capsules at doses of 0.4 mg and 0.8 mg compared to placebo. The x-axis shows the duration of treatment in weeks, while the y-axis shows the mean change. Data points include sample sizes at various time points, illustrating a greater mean change with active treatments versus placebo.*

FDA Label Image

Structured Formula For Tamsulosin (B24163d2 7af8 49c1 A85c 1cd015e29dd0 04)

A line graph showing mean change over time (weeks) in a treatment study comparing Tamsulosin Hydrochloride at 0.4 mg and 0.8 mg dosages versus placebo. The x-axis represents duration of treatment in weeks, and the y-axis represents mean change. The graph includes three distinct trend lines for each treatment group across multiple time points.*

FDA Label Image

Structured Formula For Tamsulosin (B24163d2 7af8 49c1 A85c 1cd015e29dd0 05)

A line graph depicting the mean change in a variable measured in mL/sec over the duration of treatment in weeks. The graph compares three groups: one receiving 0.8 mg treatment, another 0.4 mg treatment, and a placebo group, showing their respective mean changes tracked across various time points up to 18 weeks.*

FDA Label Image

Structured Formula For Tamsulosin (B24163d2 7af8 49c1 A85c 1cd015e29dd0 06)

A line graph showing mean change in mL/sec over treatment duration in weeks for Tamsulosin Hydrochloride at doses 0.8 mg, 0.4 mg, and placebo. The x-axis is labeled 'Duration of Treatment (weeks)' and the y-axis 'Mean Change (mL/sec)'. The graph compares the three treatments across weeks 0, 1, 2, 5, 9, 13, and LOCF with sample sizes shown below the x-axis.*

FDA Label Image

Tamsulosin HCl Capsules, 0.4 mg (B24163d2 7af8 49c1 A85c 1cd015e29dd0 07)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, oral capsules packaged in a container of 1,000 count. The label shows the NDC 82009-025-10 and indicates the product is Rx only. Manufactured by Zydus Lifesciences Ltd., India, and for Quallent Pharmaceuticals Health LLC. Storage instructions and dosage directions are partially noted with reference to the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.